ANS CARDIO FDA 510K CLEARED ASSESSMENT TESTING SYSTEM - HIGHLIGHTS

ANS Cardio is an FDA 510k cleared test that accurately and effectively assesses cardiovascular health. This simple-to-use device uses advanced and innovative technology to analyze your pulse wave velocity and measure vascular elasticity and stiffness. In less than 5 minutes, ANS Cardio accurately provides the biological age of arteries, utilizing a finger probe to observe changes in blood flow, velocity and profile throughout the whole pulse wave.

According to the Centers for Disease Control and Prevention, about 600,000 people die of heart disease in the United States every year*. Cardiovascular disease causes more deaths than cancer and chronic lower respiratory disease combined**. Some predictors of cardiovascular disease include autonomic imbalance, hypertension, stress, plaque buildup and family history.

EARLY DETECTION SAVES LIVES - ANS Cardio provides a safe and effective way to detect early symptoms of cardiovascular disease.

ANS Cardio should be used for patients with any of the following conditions, medical history or treatments:

  • Diabetes with Neurological Manifestations
  • Amyloidosis
  • Basal Ganglia
  • Idiopathic Peripheral Autonomic Neuropathy
  • Reflex Sympathetic Dystrophy
  • Idiopathic Progressive Polyneuropathy
  • Orthostatic Hypotension
  • Hyperhidrosis
  • Supraventricular Tachycardia
  • Syncope and Collapse Common faint (NMS)
  • Orthostatic Hypotension
  • Cardiac Syncope
  • * Murphy SL, Xu JQ, Kochanek KD. Deaths: Final data for 2010. Natl Vital Stat Rep. 2013;61(4). http://www.cdc.gov/nchs/data/nvsr/nvsr61/nvsr61_04.pdf[PDF-3M]t
    ** Centers for Disease Control and Prevention, National Center for Health Statistics. Compressed Mortality File 1999–2010. Series 20 No. 2P. CDC WONDER Online Database. As cited in the Heart Disease and Stroke Statistics – 2014 Update: A Report from the American Heart Association, p 117. Published online December 18, 2013. Downloaded from http://circ.ahajournals.org. Accessed July 11, 2014.